Prostate Cancer Debate
Reflections on advanced prostate cancer management

19 October 2017, 13:00–18:00

20 October 2017, 08:30–13:00

Crowne Plaza

Berlin, Germany

Scientific Committee:

Prof. Heather Payne, United Kingdom

Prof. Kurt Miller, Germany

Programme


Thursday 19 October

13:00-13:20 Introduction
13:20-13:40 Is the future now? Exploring biomarkers and future treatment options
13:40-14:55 Workshops: session 1
15:10-15:30 Optimised treatment of metastatic prostate cancer
15:30-16:30 Optimised treatment of metastatic prostate cancer:
interactive clinical cases and panel discussion
16:30-17:45 Workshops: session 2
17:45-18:00 Conclusion Day 1

Friday 20 October

08:30-08:45 Introduction
08:45-10:30 Expert Forum: deliberations in mCRPC treatment
Docetaxel, abiraterone acetate plus prednisone, enzalutamide, radium 223
10:45-12:00 Workshops: session 3
12:00-12:45 Reflections on advanced prostate cancer management
Concluding discussion and Q&A
12:45-13:00 Conclusion of meeting

This event is intended for oncologists and urologists actively treating patients with advanced prostate cancer.

For more information, please complete this form:

With support from Janssen Pharmaceutical Companies of Johnson & Johnson in EMEA

Janssen Pharmaceutica NV
Turnhoutsweg 30
B-2340 Beerse, Belgium

Date of preparation: July 2017
PHEM/ONCS/0417/0002d